Comparison of the effect of direct-acting antiviral with and without ribavirin on cyclosporine and tacrolimus clearance values: results from the ANRS CO23 CUPILT cohort.

European Journal of Clinical Pharmacology
Aurélie Barrail-TranAudrey Coilly

Abstract

Direct-acting antiviral agents have demonstrated their efficacy in treating HCV recurrence after liver transplantation and particularly the sofosbuvir/daclatasvir combination. Pharmacokinetic data on both calcineurin inhibitors and direct-acting antiviral exposure in liver transplant recipients remain sparse. Patients were enrolled from the ANRS CO23 CUPILT cohort. All patients treated with sofosbuvir/daclatasvir with or without ribavirin were included in this study when blood samples were available to estimate the clearance of immunosuppressive therapy before direct-acting antiviral initiation and during follow-up. Apparent tacrolimus and cyclosporine clearances were estimated from trough concentrations measured using validated quality control assays. Sixty-seven mainly male patients (79%) were included, with a mean age of 57 years and mean MELD score of 8.2; 50 were on tacrolimus, 17 on cyclosporine. Ribavirin was combined with sofosbuvir/daclatasvir in 52% of patients. Cyclosporine clearance remained unchanged as well as tacrolimus clearance under the ribavirin-free regimen. Tacrolimus clearance increased 4 weeks after direct-acting antivirals and ribavirin initiation versus baseline (geometric mean ratio 1.81; 90% CI 1.30-2...Continue Reading

References

Oct 24, 2007·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·L A FrassettoL Z Benet
Feb 18, 2015·Transplantation Reviews·Nauras ShukerDennis A Hesselink
May 15, 2015·The Journal of Antimicrobial Chemotherapy·Joseph E RowerJennifer J Kiser
Aug 14, 2015·Transplant International : Official Journal of the European Society for Organ Transplantation·Yoshihide Ueda, Shinji Uemoto
Sep 4, 2015·World Journal of Gastroenterology : WJG·Evangelos CholongitasGeorge Papatheodoridis
Jan 13, 2016·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Fred PoordadEugene S Swenson
Feb 19, 2016·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Robert J FontanaK Rajender Reddy
Feb 26, 2016·Drug Metabolism Reviews·Thomas VanhoveDirk R J Kuypers
Jun 6, 2016·Journal of Hepatology·Audrey CoillyUNKNOWN ANRS C023 CUPILT study group
Jun 21, 2016·Transplantation Proceedings·S LimsrichamrernW Dumronggittigule
Oct 28, 2016·British Journal of Clinical Pharmacology·Sarah Talavera PonsArmand Abergel
Nov 2, 2016·Transplant Infectious Disease : an Official Journal of the Transplantation Society·Nathanael RaschzokMartin Stockmann

❮ Previous
Next ❯

Clinical Trials Mentioned

NCT01944527

Software Mentioned

SAS

Related Concepts

Related Feeds

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Related Papers

The Lancet Infectious Diseases
Stelliana GoutzamanisPeter Higgs
Antiviral Therapy
Alexander J Thompson, Stephen Locarnini
Journal of Clinical and Experimental Hepatology
Madhumita Premkumar, Radha K Dhiman
© 2021 Meta ULC. All rights reserved